United States · FDA National Drug Code directory
Deferasirox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73190-052_485c4f9f-883c-2579-e063-6294a90adbfe
- Product NDC
- 73190-052
- Form
- TABLET
- Composition / generic term
- Deferasirox
- Labeler
- AvKARE
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260114
- Source listing expiry
- 20271231
Source-listed ingredients
- DEFERASIROX — 360 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (73190-052-30) · 73190-052-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →